Iambic, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, published on major advances to Enchant, Iambic's ...

Recursion Pharmaceuticals could benefit from FDA’s AI shift despite risks, with scalable tech and long-term potential. Find ...

CAMBRIDGE, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated ...

The global lung cancer therapeutics market is on a robust growth trajectory, poised to witness a significant transformation over the next decade. According to recent market projections, the industry ...

Fast Track Designation highlights potential of ATH434 to address high unmet need for individuals with MSA – MELBOURNE, Australia and SAN FRANCISCO, May 05, 2025 (GLOBE NEWSWIRE) -- Alterity ...

Fast Track Designation highlights potential of ATH434 to address high unmet need for individuals with MSA - MELBOURNE, Australia and SAN FRANCISCO, May 05, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeuti ...

The below recap contains spoilers for Watson Episode 12. The first half of Watson’s two-part season finale is the first time ...

Monash University scientists have identified a potential new drug target to alleviate neuroinflammation, which is reported in ...

A biomedical engineering professor is aiming for future trials to test a drug with surprising heart-healing potential.

Gujarat Natural Resources Ltd along with GNRL Oil & Gas Ltd has commenced its 7 well drilling campaign with drilling of K#12 in Kanawara field targeting development object of EPIV oil reservoir and ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...